Here’s how a drug gets from an idea into patients’ hands – and why Australians sometimes wait longer to access a new drug ...

GEA Group maintains a conservative balance sheet, helping to shield shareholders from the inherent volatility in capital equipment spending in GEA’s various end markets. The balance sheet sits in a ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

Healthcare analyst Ellen Andrews, Ph. D, highlights a first-in-the-nation bill that the state passed this year in an effort to control generic drug prices.

An exploratory analysis at the one-year mark further demonstrated a continued survival benefit, with patients randomized to 300 mg of dazucorilant living significantly longer than those who ...

Teva Pharmaceutical Industries Ltd. announced the final analysis of the PEARL Phase 4 study at the European Academy of Neurology Congress 2025, confirming that AJOVY (fremanezumab) is effective in ...

The true cost of dementia care in the U.S. is far higher than reported because it relies heavily on unpaid care from family and friends.

We assumed API procurement and formulation of finished pharmaceutical product (FPP) in India due to its large generic industry and historical importance in treatment of the HIV epidemic. 6 The main ...

The new survey, “ Beyond the Shortage: The Hidden Cost of Drug Supply Chain Disruptions,” revealed that in 2023, hospitals across the U.S. spent roughly 20 million hours managing a range of ...

Collaboration brings low-cost obesity medications plus expert-led, whole-body care to employer benefit plans. SAN DIEGO and DALLAS, June 17, 2025 /PRNewswire/ -- 9amHealth, a leader in complete ...

June 17, 2020, Paper, "Benefit-cost analysis (BCA) is often viewed as measuring the efficiency of a policy independent of the distribution of its consequences. The role of distributional effects on ...